Physician profile
Scott E Glaser
NPI 1881691863
$9,192.07
in general payments reported to CMS, 2019-2025
21 companies · $1,317 in 2025
The $1,317 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $4,236 · 2021: $426 · 2022: $420 · 2023: $1,743 · 2024: $790 · 2025: $1,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,716 · Travel and Lodging: $1,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,716.08 |
| Travel and Lodging | $1,134.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $4,000.00 | 2020 | |
| Boston Scientific Corporation | $2,294.41 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Spinal Simplicity, LLC | $1,829.52 | 2023-2025 | Ha Minuteman G3-R |
| Abbott Laboratories | $214.41 | 2021-2024 | Eterna |
| Vertiflex, INC. | $124.23 | 2019 | |
| Nevro Corp. | $99.67 | 2020-2021 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $83.07 | 2024-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $71.04 | 2019-2025 | |
| Si-Bone, INC. | $64.73 | 2019-2025 | |
| Saluda Medical Americas, INC. | $54.70 | 2024-2025 | Evoke |
| Medtronic, INC. | $40.78 | 2023 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.39 | 2025 | Relistor |
| Globus Medical, INC. | $31.78 | 2025 | Senza |
| Avanos Medical | $23.61 | 2023 | Genvisc 850 Sodium Hyaluronate |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $23.11 | 2020 | |
| Ani Pharmaceuticals, INC. | $22.88 | 2025 | Purified Cortrophin Gel |
| Nalu Medical, INC. | $21.58 | 2025 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $20.96 | 2025 | Sprint Pns System |
| Depuy Synthes Sales INC. | $19.06 | 2025 | Orthovisc |
| Valinor Pharma, LLC | $14.19 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Glaser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.